Phase 2 monotherapy expansion dose selected for enrollment in high priority MTAP-deletion solid tumor types – NSCLC, bladder and gastroesophageal cancers Observed partial response by RECIST 1.1 (~40% tumor reduction) at first post-baseline scan in a pre-treated patient having a high…

NEW YORK, June 12, 2023 /PRNewswire/ — The collagen market size is estimated to increase by USD 2,866.14 million from 2022 to 2027. The market’s growth momentum will progress at a CAGR of 7.75%. The rising demand for collagen from the healthcare industry is one of the major drivers of…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.